According to this latest study, the 2021 growth of Mebendazole will have significant change from previous year. By the most conservative estimates of global Mebendazole market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 108.9 million in 2020. Over the next five years the Mebendazole market will register a 5.8% CAGR in terms of revenue, the global market size will reach US$ 136.5 million by 2026.
This report presents a comprehensive overview, market shares, and growth opportunities of Mebendazole market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Tablet
Oral Suspension
Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Below 2 Years Old
Above 2 Years Old
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Johnson & Johnson
Amneal Pharmaceuticals
Cadila Pharmaceuticals
Eipico
Esteve Pharmaceuticals
Tenry
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Mebendazole Consumption 2016-2026
2.1.2 Mebendazole Consumption CAGR by Region
2.2 Mebendazole Segment by Type
2.2.1 Tablet
2.2.2 Oral Suspension
2.3 Mebendazole Sales by Type
2.3.1 Global Mebendazole Sales Market Share by Type (2016-2021)
2.3.2 Global Mebendazole Revenue and Market Share by Type (2016-2021)
2.3.3 Global Mebendazole Sale Price by Type (2016-2021)
2.4 Mebendazole Segment by Application
2.4.1 Below 2 Years Old
2.4.2 Above 2 Years Old
2.5 Mebendazole Sales by Application
2.5.1 Global Mebendazole Sale Market Share by Application (2016-2021)
2.5.2 Global Mebendazole Revenue and Market Share by Application (2016-2021)
2.5.3 Global Mebendazole Sale Price by Application (2016-2021)
3 Global Mebendazole by Company
3.1 Global Mebendazole Sales Market Share by Company
3.1.1 Global Mebendazole Sales by Company (2019-2021)
3.1.2 Global Mebendazole Sales Market Share by Company (2019-2021)
3.2 Global Mebendazole Revenue Market Share by Company
3.2.1 Global Mebendazole Revenue by Company (2019-2021)
3.2.2 Global Mebendazole Revenue Market Share by Company (2019-2021)
3.3 Global Mebendazole Sale Price by Company
3.4 Global Manufacturers Mebendazole Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Mebendazole Product Location Distribution
3.4.2 Players Mebendazole Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Mebendazole by Region
4.1 Global Mebendazole by Region
4.1.1 Global Mebendazole Sales by Region
4.1.2 Global Mebendazole Revenue by Region
4.2 Americas Mebendazole Sales Growth
4.3 APAC Mebendazole Sales Growth
4.4 Europe Mebendazole Sales Growth
4.5 Middle East & Africa Mebendazole Sales Growth
5 Americas
5.1 Americas Mebendazole Sales by Country
5.1.1 Americas Mebendazole Sales by Country (2016-2021)
5.1.2 Americas Mebendazole Revenue by Country (2016-2021)
5.2 Americas Mebendazole Sales by Type
5.3 Americas Mebendazole Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mebendazole Sales by Region
6.1.1 APAC Mebendazole Sales by Region (2016-2021)
6.1.2 APAC Mebendazole Revenue by Region (2016-2021)
6.2 APAC Mebendazole Sales by Type
6.3 APAC Mebendazole Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Mebendazole by Country
7.1.1 Europe Mebendazole Sales by Country (2016-2021)
7.1.2 Europe Mebendazole Revenue by Country (2016-2021)
7.2 Europe Mebendazole Sales by Type
7.3 Europe Mebendazole Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Mebendazole by Country
8.1.1 Middle East & Africa Mebendazole Sales by Country (2016-2021)
8.1.2 Middle East & Africa Mebendazole Revenue by Country (2016-2021)
8.2 Middle East & Africa Mebendazole Sales by Type
8.3 Middle East & Africa Mebendazole Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Mebendazole Distributors
10.3 Mebendazole Customer
11 Global Mebendazole Market Forecast
11.1 Global Mebendazole Forecast by Region
11.1.1 Global Mebendazole Forecast by Regions (2021-2026)
11.2.2 Global Mebendazole Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Mebendazole Forecast by Type
11.7 Global Mebendazole Forecast by Application
12 Key Players Analysis
12.1 Johnson & Johnson
12.1.1 Johnson & Johnson Company Information
12.1.2 Johnson & Johnson Mebendazole Product Offered
12.1.3 Johnson & Johnson Mebendazole Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Johnson & Johnson Main Business Overview
12.1.5 Johnson & Johnson Latest Developments
12.2 Amneal Pharmaceuticals
12.2.1 Amneal Pharmaceuticals Company Information
12.2.2 Amneal Pharmaceuticals Mebendazole Product Offered
12.2.3 Amneal Pharmaceuticals Mebendazole Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Amneal Pharmaceuticals Main Business Overview
12.2.5 Amneal Pharmaceuticals Latest Developments
12.3 Cadila Pharmaceuticals
12.3.1 Cadila Pharmaceuticals Company Information
12.3.2 Cadila Pharmaceuticals Mebendazole Product Offered
12.3.3 Cadila Pharmaceuticals Mebendazole Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Cadila Pharmaceuticals Main Business Overview
12.3.5 Cadila Pharmaceuticals Latest Developments
12.4 Eipico
12.4.1 Eipico Company Information
12.4.2 Eipico Mebendazole Product Offered
12.4.3 Eipico Mebendazole Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Eipico Main Business Overview
12.4.5 Eipico Latest Developments
12.5 Esteve Pharmaceuticals
12.5.1 Esteve Pharmaceuticals Company Information
12.5.2 Esteve Pharmaceuticals Mebendazole Product Offered
12.5.3 Esteve Pharmaceuticals Mebendazole Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Esteve Pharmaceuticals Main Business Overview
12.5.5 Esteve Pharmaceuticals Latest Developments
12.6 Tenry
12.6.1 Tenry Company Information
12.6.2 Tenry Mebendazole Product Offered
12.6.3 Tenry Mebendazole Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Tenry Main Business Overview
12.6.5 Tenry Latest Developments
...
13 Research Findings and Conclusion
List of Tables
Table 1. Mebendazole Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Tablet
Table 3. Major Players of Oral Suspension
Table 4. Global Mebendazole Sales by Type (2016-2021) & (K Units)
Table 5. Global Mebendazole Sales Market Share by Type (2016-2021)
Table 6. Global Mebendazole Revenue by Type (2016-2021) & ($ million)
Table 7. Global Mebendazole Revenue Market Share by Type (2016-2021)
Table 8. Global Mebendazole Sale Price by Type (2016-2021)
Table 9. Global Mebendazole Sales by Application (2016-2021) & (K Units)
Table 10. Global Mebendazole Sales Market Share by Application (2016-2021)
Table 11. Global Mebendazole Value by Application (2016-2021)
Table 12. Global Mebendazole Revenue Market Share by Application (2016-2021)
Table 13. Global Mebendazole Sale Price by Application (2016-2021)
Table 14. Global Mebendazole Sales by Company (2019-2021) & (K Units)
Table 15. Global Mebendazole Sales Market Share by Company (2019-2021)
Table 16. Global Mebendazole Revenue by Company (2019-2021) ($ Millions)
Table 17. Global Mebendazole Revenue Market Share by Company (2019-2021)
Table 18. Global Mebendazole Sale Price by Company (2019-2021)
Table 19. Key Manufacturers Mebendazole Producing Area Distribution and Sales Area
Table 20. Players Mebendazole Products Offered
Table 21. Mebendazole Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Mebendazole Sales by Region (2016-2021) (K Units)
Table 25. Global Mebendazole Sales Market Share by Region (2016-2021)
Table 26. Global Mebendazole Revenue by Region (2016-2021) & ($ Millions)
Table 27. Global Mebendazole Revenue Market Share by Region (2016-2021)
Table 28. Americas Mebendazole Sales by Country (2016-2021) & (K Units)
Table 29. Americas Mebendazole Sales Market Share by Country (2016-2021)
Table 30. Americas Mebendazole Revenue by Country (2016-2021) & ($ Millions)
Table 31. Americas Mebendazole Revenue Market Share by Country (2016-2021)
Table 32. Americas Mebendazole Sales by Type (2016-2021) & (K Units)
Table 33. Americas Mebendazole Sales Market Share by Type (2016-2021)
Table 34. Americas Mebendazole Sales by Application (2016-2021) & (K Units)
Table 35. Americas Mebendazole Sales Market Share by Application (2016-2021)
Table 36. APAC Mebendazole Sales by Region (2016-2021) & (K Units)
Table 37. APAC Mebendazole Sales Market Share by Region (2016-2021)
Table 38. APAC Mebendazole Revenue by Region (2016-2021) & ($ Millions)
Table 39. APAC Mebendazole Revenue Market Share by Region (2016-2021)
Table 40. APAC Mebendazole Sales by Type (2016-2021) & (K Units)
Table 41. APAC Mebendazole Sales Market Share by Type (2016-2021)
Table 42. APAC Mebendazole Sales by Application (2016-2021) & (K Units)
Table 43. APAC Mebendazole Sales Market Share by Application (2016-2021)
Table 44. Europe Mebendazole Sales by Country (2016-2021) & (K Units)
Table 45. Europe Mebendazole Sales Market Share by Country (2016-2021)
Table 46. Europe Mebendazole Revenue by Country (2016-2021) & ($ Millions)
Table 47. Europe Mebendazole Revenue Market Share by Country (2016-2021)
Table 48. Europe Mebendazole Sales by Type (2016-2021) & (K Units)
Table 49. Europe Mebendazole Sales Market Share by Type (2016-2021)
Table 50. Europe Mebendazole Sales by Application (2016-2021) & (K Units)
Table 51. Europe Mebendazole Sales Market Share by Application (2016-2021)
Table 52. Middle East & Africa Mebendazole Sales by Country (2016-2021) & (K Units)
Table 53. Middle East & Africa Mebendazole Sales Market Share by Country (2016-2021)
Table 54. Middle East & Africa Mebendazole Revenue by Country (2016-2021) & ($ Millions)
Table 55. Middle East & Africa Mebendazole Revenue Market Share by Country (2016-2021)
Table 56. Middle East & Africa Mebendazole Sales by Type (2016-2021) & (K Units)
Table 57. Middle East & Africa Mebendazole Sales Market Share by Type (2016-2021)
Table 58. Middle East & Africa Mebendazole Sales by Application (2016-2021) & (K Units)
Table 59. Middle East & Africa Mebendazole Sales Market Share by Application (2016-2021)
Table 60. Key and Potential Regions of Mebendazole
Table 61. Key Application and Potential Industries of Mebendazole
Table 62. Key Challenges of Mebendazole
Table 63. Key Trends of Mebendazole
Table 64. Mebendazole Distributors List
Table 65. Mebendazole Customer List
Table 66. Global Mebendazole Sales Forecast by Region (2021-2026) & (K Units)
Table 67. Global Mebendazole Consumption Market Forecast by Region
Table 68. Global Mebendazole Revenue Forecast by Region (2021-2026) & ($ millions)
Table 69. Global Mebendazole Revenue Market Share Forecast by Region (2021-2026)
Table 70. Americas Mebendazole Sales Forecast by Country (2021-2026) & (K Units)
Table 71. Americas Mebendazole Revenue Forecast by Country (2021-2026) & ($ millions)
Table 72. APAC Mebendazole Sales Forecast by Region (2021-2026) & (K Units)
Table 73. APAC Mebendazole Revenue Forecast by Region (2021-2026) & ($ millions)
Table 74. Europe Mebendazole Sales Forecast by Country (2021-2026) & (K Units)
Table 75. Europe Mebendazole Revenue Forecast by Country (2021-2026) & ($ millions)
Table 76. Middle East & Africa Mebendazole Sales Forecast by Country (2021-2026) & (K Units)
Table 77. Middle East & Africa Mebendazole Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Global Mebendazole Sales Forecast by Type (2021-2026) & (K Units)
Table 79. Global Mebendazole Sales Market Share Forecast by Type (2021-2026)
Table 80. Global Mebendazole Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 81. Global Mebendazole Revenue Market Share Forecast by Type (2021-2026)
Table 82. Global Mebendazole Sales Forecast by Application (2021-2026) & (K Units)
Table 83. Global Mebendazole Sales Market Share Forecast by Application (2021-2026)
Table 84. Global Mebendazole Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 85. Global Mebendazole Revenue Market Share Forecast by Application (2021-2026)
Table 86. Johnson & Johnson Basic Information, Mebendazole Manufacturing Base, Sales Area and Its Competitors
Table 87. Johnson & Johnson Mebendazole Product Offered
Table 88. Johnson & Johnson Mebendazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 89. Johnson & Johnson Main Business
Table 90. Johnson & Johnson Latest Developments
Table 91. Amneal Pharmaceuticals Basic Information, Mebendazole Manufacturing Base, Sales Area and Its Competitors
Table 92. Amneal Pharmaceuticals Mebendazole Product Offered
Table 93. Amneal Pharmaceuticals Mebendazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 94. Amneal Pharmaceuticals Main Business
Table 95. Amneal Pharmaceuticals Latest Developments
Table 96. Cadila Pharmaceuticals Basic Information, Mebendazole Manufacturing Base, Sales Area and Its Competitors
Table 97. Cadila Pharmaceuticals Mebendazole Product Offered
Table 98. Cadila Pharmaceuticals Mebendazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 99. Cadila Pharmaceuticals Main Business
Table 100. Cadila Pharmaceuticals Latest Developments
Table 101. Eipico Basic Information, Mebendazole Manufacturing Base, Sales Area and Its Competitors
Table 102. Eipico Mebendazole Product Offered
Table 103. Eipico Mebendazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 104. Eipico Main Business
Table 105. Eipico Latest Developments
Table 106. Esteve Pharmaceuticals Basic Information, Mebendazole Manufacturing Base, Sales Area and Its Competitors
Table 107. Esteve Pharmaceuticals Mebendazole Product Offered
Table 108. Esteve Pharmaceuticals Mebendazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 109. Esteve Pharmaceuticals Main Business
Table 110. Esteve Pharmaceuticals Latest Developments
Table 111. Tenry Basic Information, Mebendazole Manufacturing Base, Sales Area and Its Competitors
Table 112. Tenry Mebendazole Product Offered
Table 113. Tenry Mebendazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 114. Tenry Main Business
Table 115. Tenry Latest Developments
List of Figures
Figure 1. Picture of Mebendazole
Figure 2. Mebendazole Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Mebendazole Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Mebendazole Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Mebendazole Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Tablet
Figure 10. Product Picture of Oral Suspension
Figure 11. Global Mebendazole Sales Market Share by Type in 2020
Figure 12. Global Mebendazole Revenue Market Share by Type (2016-2021)
Figure 13. Mebendazole Consumed in Below 2 Years Old
Figure 14. Global Mebendazole Market: Below 2 Years Old (2016-2021) & (K Units)
Figure 15. Mebendazole Consumed in Above 2 Years Old
Figure 16. Global Mebendazole Market: Above 2 Years Old (2016-2021) & (K Units)
Figure 17. Global Mebendazole Sales Market Share by Application (2016-2021)
Figure 18. Global Mebendazole Revenue Market Share by Application in 2020
Figure 19. Mebendazole Revenue Market by Company in 2020 ($ Million)
Figure 20. Global Mebendazole Revenue Market Share by Company in 2020
Figure 21. Global Mebendazole Sales Market Share by Regions (2016-2021)
Figure 22. Global Mebendazole Revenue Market Share by Region in 2020
Figure 23. Americas Mebendazole Sales 2016-2021 (K Units)
Figure 24. Americas Mebendazole Revenue 2016-2021 ($ Millions)
Figure 25. APAC Mebendazole Sales 2016-2021 (K Units)
Figure 26. APAC Mebendazole Revenue 2016-2021 ($ Millions)
Figure 27. Europe Mebendazole Sales 2016-2021 (K Units)
Figure 28. Europe Mebendazole Revenue 2016-2021 ($ Millions)
Figure 29. Middle East & Africa Mebendazole Sales 2016-2021 (K Units)
Figure 30. Middle East & Africa Mebendazole Revenue 2016-2021 ($ Millions)
Figure 31. Americas Mebendazole Sales Market Share by Country in 2020
Figure 32. Americas Mebendazole Revenue Market Share by Country in 2020
Figure 33. Americas Mebendazole Sales Market Share by Type in 2020
Figure 34. Americas Mebendazole Sales Market Share by Application in 2020
Figure 35. United States Mebendazole Revenue Growth 2016-2021 ($ Millions)
Figure 36. Canada Mebendazole Revenue Growth 2016-2021 ($ Millions)
Figure 37. Mexico Mebendazole Revenue Growth 2016-2021 ($ Millions)
Figure 38. Brazil Mebendazole Revenue Growth 2016-2021 ($ Millions)
Figure 39. APAC Mebendazole Sales Market Share by Region in 2020
Figure 40. APAC Mebendazole Revenue Market Share by Regions in 2020
Figure 41. APAC Mebendazole Sales Market Share by Type in 2020
Figure 42. APAC Mebendazole Sales Market Share by Application in 2020
Figure 43. China Mebendazole Revenue Growth 2016-2021 ($ Millions)
Figure 44. Japan Mebendazole Revenue Growth 2016-2021 ($ Millions)
Figure 45. Korea Mebendazole Revenue Growth 2016-2021 ($ Millions)
Figure 46. Southeast Asia Mebendazole Revenue Growth 2016-2021 ($ Millions)
Figure 47. India Mebendazole Revenue Growth 2016-2021 ($ Millions)
Figure 48. Australia Mebendazole Revenue Growth 2016-2021 ($ Millions)
Figure 49. Europe Mebendazole Sales Market Share by Country in 2020
Figure 50. Europe Mebendazole Revenue Market Share by Country in 2020
Figure 51. Europe Mebendazole Sales Market Share by Type in 2020
Figure 52. Europe Mebendazole Sales Market Share by Application in 2020
Figure 53. Germany Mebendazole Revenue Growth 2016-2021 ($ Millions)
Figure 54. France Mebendazole Revenue Growth 2016-2021 ($ Millions)
Figure 55. UK Mebendazole Revenue Growth 2016-2021 ($ Millions)
Figure 56. Italy Mebendazole Revenue Growth 2016-2021 ($ Millions)
Figure 57. Russia Mebendazole Revenue Growth 2016-2021 ($ Millions)
Figure 58. Middle East & Africa Mebendazole Sales Market Share by Country in 2020
Figure 59. Middle East & Africa Mebendazole Revenue Market Share by Country in 2020
Figure 60. Middle East & Africa Mebendazole Sales Market Share by Type in 2020
Figure 61. Middle East & Africa Mebendazole Sales Market Share by Application in 2020
Figure 62. Egypt Mebendazole Revenue Growth 2016-2021 ($ Millions)
Figure 63. South Africa Mebendazole Revenue Growth 2016-2021 ($ Millions)
Figure 64. Israel Mebendazole Revenue Growth 2016-2021 ($ Millions)
Figure 65. Turkey Mebendazole Revenue Growth 2016-2021 ($ Millions)
Figure 66. GCC Country Mebendazole Revenue Growth 2016-2021 ($ Millions)
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles